TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive President’s Budget Asks Increase of 8.5 Percent For NCI In FY 1989; Still No Construction Money February 26, 1988
TCL Archive Increase In Recommended Levels, OMB’s Forward Funding Create Shortfall In Center’s Budget April 19, 1985
